Arcoma AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
04-25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01-29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 183M 16.97M 0 23.15M | Sales 2025 * | 199M 18.46M 0 25.17M | Capitalization | 185M 17.18M 0 23.44M |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.3M - 1.77M | Net income 2025 * | 16M 1.48M - 2.02M | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | 7M 649K 0 886K | Net cash position 2025 * | 19M 1.76M 0 2.4M | EV / Sales 2025 * | 0.84 x |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
11.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 53 | 93-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-12-31 | |
Director/Board Member | 53 | 10-02-28 | |
Lars Kvarnhem
CHM | Chairman | 52 | 16-12-31 |
1st Jan change | Capi. | |
---|---|---|
-0.97% | 15.37B | |
-36.20% | 2.92B | |
-12.03% | 2.48B | |
-12.41% | 1.45B | |
-.--% | 1.12B | |
+65.31% | 609M | |
+88.97% | 499M | |
+18.25% | 249M | |
-2.35% | 225M |